This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2014 Oct 13;56(1453):100-1.

A stool DNA test (Cologuard) for colorectal cancer screening

No authors listed

PMID: 25296259

A stool DNA test (Cologuard) for colorectal cancer screening

No authors listed. Med Lett Drugs Ther. 2014.

. 2014 Oct 13;56(1453):100-1.

PMID: 25296259

No abstract available

PubMed Disclaimer

Republished in

A stool DNA test (Cologuard) for colorectal cancer screening.
[No authors listed] [No authors listed] JAMA. 2014 Dec 17;312(23):2566. doi: 10.1001/jama.2014.15746. JAMA. 2014. PMID: 25514307 No abstract available.

Similar articles

Stool DNA and colorectal-cancer screening.
Robertson DJ, Dominitz JA. Robertson DJ, et al. N Engl J Med. 2014 Apr 3;370(14):1350-1. doi: 10.1056/NEJMe1400092. Epub 2014 Mar 19. N Engl J Med. 2014. PMID: 24645801 No abstract available.
Fecal DNA analysis for colorectal cancer screening.
Blue Cross Blue Shield Asssociation. Blue Cross Blue Shield Asssociation. Technol Eval Cent Assess Program Exec Summ. 2014 Dec;29(8):1-2. Technol Eval Cent Assess Program Exec Summ. 2014. PMID: 25577821 No abstract available.
Multitarget stool DNA testing for colorectal-cancer screening.
Souverijn JH. Souverijn JH. N Engl J Med. 2014 Jul 10;371(2):187. doi: 10.1056/NEJMc1405215. N Engl J Med. 2014. PMID: 25006740 No abstract available.
Multi-Target Stool DNA Test: Is the Future Here?
Sweetser S, Ahlquist DA. Sweetser S, et al. Curr Gastroenterol Rep. 2016 Jun;18(6):30. doi: 10.1007/s11894-016-0510-4. Curr Gastroenterol Rep. 2016. PMID: 27165404 Review.
Stool DNA screening for colorectal neoplasia: biological and technical basis for high detection rates.
Berger BM, Ahlquist DA. Berger BM, et al. Pathology. 2012 Feb;44(2):80-8. doi: 10.1097/PAT.0b013e3283502fdf. Pathology. 2012. PMID: 22198259 Review.

See all similar articles

Cited by

Using bioinformatics approaches to investigate driver genes and identify BCL7A as a prognostic gene in colorectal cancer.
Chao JY, Chang HC, Jiang JK, Yang CY, Chen FH, Lai YL, Lin WJ, Li CY, Wang SC, Yang MH, Lin YF, Cheng WC. Chao JY, et al. Comput Struct Biotechnol J. 2021 Jul 1;19:3922-3929. doi: 10.1016/j.csbj.2021.06.044. eCollection 2021. Comput Struct Biotechnol J. 2021. PMID: 34306573 Free PMC article.
Cost Effectiveness of Screening Colonoscopy Depends on Adequate Bowel Preparation Rates - A Modeling Study.
Kingsley J, Karanth S, Revere FL, Agrawal D. Kingsley J, et al. PLoS One. 2016 Dec 9;11(12):e0167452. doi: 10.1371/journal.pone.0167452. eCollection 2016. PLoS One. 2016. PMID: 27936028 Free PMC article.
Point-of-care testing in the diagnosis of gastrointestinal cancers: current technology and future directions.
Huddy JR, Ni MZ, Markar SR, Hanna GB. Huddy JR, et al. World J Gastroenterol. 2015 Apr 14;21(14):4111-20. doi: 10.3748/wjg.v21.i14.4111. World J Gastroenterol. 2015. PMID: 25892860 Free PMC article. Review.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Medical Letter on Drugs and Therapeutics
Medical
- MedlinePlus Health Information